Literature DB >> 28939925

Ocular adnexal marginal zone lymphoma of mucosa-associated lymphoid tissue.

Dimitrios Kalogeropoulos1, Alexandra Papoudou-Bai2, Panagiotis Kanavaros3, Chris Kalogeropoulos4.   

Abstract

Ocular adnexal lymphomas are a group of heterogeneous neoplasms representing approximately 1-2% of non-Hodgkin lymphomas and 8% of extranodal lymphomas. The incidence of primary ocular adnexal lymphoid tumors has raised over the last decades, and this could be probably attributed to the more sophisticated diagnostic techniques. Due to the wide spectrum of clinical manifestations, ocular tissue biopsy is important in order to set a precise diagnosis based on histological, immunophenotypical and, in some cases, molecular findings. The most common subtype, which may account for up to 80% of primary ocular adnexal lymphomas, is extranodal marginal zone lymphoma (EMZL) of mucosa-associated lymphoid tissue. This lymphoma is usually asymptomatic in the early phase of the disease causing a delay in the final diagnosis and prompt therapy. The pathogenesis of a proportion of these tumors has been linked to chronic inflammatory stimulation from specific infectious factors (e.g., Chlamydia psittaci) or to autoimmunity. The further improvement in diagnostic methods and the further understanding of the pathogenesis of ocular adnexal EMZL may contribute to the establishment of a more successful multidisciplinary therapeutic planning.

Entities:  

Keywords:  Chronic inflammatory stimulation; Extranodal marginal zone lymphoma; Immunohistochemistry; Mucosa-associated lymphoid tissue; Ocular adnexal lymphomas

Mesh:

Year:  2017        PMID: 28939925     DOI: 10.1007/s10238-017-0474-1

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  123 in total

1.  Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone.

Authors:  N Di Gaetano; Y Xiao; E Erba; R Bassan; A Rambaldi; J Golay; M Introna
Journal:  Br J Haematol       Date:  2001-09       Impact factor: 6.998

2.  Positron emission tomography in the detection and staging of ocular adnexal lymphoproliferative disease.

Authors:  Alejandra A Valenzuela; Christopher Allen; David Grimes; David Wong; Timothy J Sullivan
Journal:  Ophthalmology       Date:  2006-09-25       Impact factor: 12.079

3.  Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the Highlands of Scotland.

Authors:  J R Goodlad; M M Davidson; K Hollowood; C Ling; C MacKenzie; I Christie; P J Batstone; D O Ho-Yen
Journal:  Am J Surg Pathol       Date:  2000-09       Impact factor: 6.394

4.  Clinical, histopathological, and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: characterization of malt lymphoma and reactive lymphoid hyperplasia.

Authors:  T Mannami; T Yoshino; K Oshima; S Takase; E Kondo; N Ohara; H Nakagawa; H Ohtsuki; M Harada; T Akagi
Journal:  Mod Pathol       Date:  2001-07       Impact factor: 7.842

5.  Expression of cyclin D3 and cyclin E and identification of distinct clusters of proliferation and apoptosis in diffuse large B-cell lymphomas.

Authors:  M Bai; E Tsanou; N J Agnantis; A Chaidos; D Dimou; A Skyrlas; S Dimou; M Vlychou; V Galani; P Kanavaros
Journal:  Histol Histopathol       Date:  2003-04       Impact factor: 2.303

6.  Rituximab and chlorambucil as first-line treatment for low-grade ocular adnexal lymphomas.

Authors:  Luigi Rigacci; Luca Nassi; Marco Puccioni; Silvia Mappa; Ennio Polito; Serena Dal Pozzo; Renato Alterini; Valentina Carrai; Benedetta Puccini; Alberto Bosi
Journal:  Ann Hematol       Date:  2007-05-05       Impact factor: 3.673

Review 7.  Antibiotic therapy in nongastrointestinal MALT lymphoma: a review of the literature.

Authors:  Barbara Kiesewetter; Markus Raderer
Journal:  Blood       Date:  2013-06-14       Impact factor: 22.113

8.  Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone b-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients.

Authors:  Eun Yoon Cho; Jae Joon Han; Howe Jung Ree; Young Hyeh Ko; Yoon-koo Kang; Hyo Sook Ahn; Seung Do Ahn; Chan Jeoung Park; Jooryung Huh
Journal:  Am J Hematol       Date:  2003-06       Impact factor: 10.047

9.  Ocular adnexal lymphoma staging and treatment: American Joint Committee on Cancer versus Ann Arbor.

Authors:  Gerardo F Graue; Paul T Finger; Elizabeth Maher; David Della Rocca; Robert Della Rocca; Gary J Lelli; Tatyana Milman
Journal:  Eur J Ophthalmol       Date:  2013-01-25       Impact factor: 2.597

10.  Somatostatin receptor scintigraphy in MALT lymphoma of the lacrimal gland treated with rituximab.

Authors:  Daniel Morgensztern; Manuel F Rosado; Aldo N Serafini; Izidore S Lossos
Journal:  Leuk Lymphoma       Date:  2004-06
View more
  7 in total

Review 1.  Involvement of Helicobacter Pylori in Ocular Adnexa Lymphoma.

Authors:  Antonio Travaglino; Mirella Pace; Silvia Varricchio; Daniela Russo; Novella Pugliese; Alessandro Severino; Marco Picardi; Fabrizio Pane; Luigi Insabato; Stefania Staibano; Massimo Mascolo
Journal:  Pathol Oncol Res       Date:  2020-06-18       Impact factor: 3.201

2.  [Retinal manifestation in hematological diseases].

Authors:  M Rehak; N Feltgen; P Meier; P Wiedemann
Journal:  Ophthalmologe       Date:  2018-09       Impact factor: 1.059

3.  A deep learning model combining multimodal radiomics, clinical and imaging features for differentiating ocular adnexal lymphoma from idiopathic orbital inflammation.

Authors:  Xiaoyang Xie; Lijuan Yang; Fengjun Zhao; Dong Wang; Hui Zhang; Xuelei He; Xin Cao; Huangjian Yi; Xiaowei He; Yuqing Hou
Journal:  Eur Radiol       Date:  2022-06-08       Impact factor: 7.034

4.  Vitreoretinal lymphoma occurring after systemic chemotherapy for primary conjunctival diffuse large B cell lymphoma: A case report.

Authors:  Erina Niidome; Yoshihiko Usui; Reisuke Takahashi; Toshitaka Nagao; Hiroshi Goto
Journal:  Medicine (Baltimore)       Date:  2021-10-01       Impact factor: 1.889

Review 5.  The Biology of Ocular Adnexal Marginal Zone Lymphomas.

Authors:  Patricia Johansson; Anja Eckstein; Ralf Küppers
Journal:  Cancers (Basel)       Date:  2022-02-28       Impact factor: 6.639

6.  Proteotranscriptomics of ocular adnexal B-cell lymphoma reveals an oncogenic role of alternative splicing and identifies a diagnostic marker.

Authors:  Jiahao Shi; Tianyu Zhu; Huimin Lin; Zhen Liu; Min Zhou; Ziyao Yu; Xiaowen Zhou; Xin Song; Yefei Wang; Renbing Jia; Xianqun Fan; Yixiong Zhou
Journal:  J Exp Clin Cancer Res       Date:  2022-07-30

7.  MALT Lymphoma Presenting with Peripheral Ulcerative Keratitis.

Authors:  Sachi Patil; Kathryn Colby; Douglas Lazzaro
Journal:  Int Med Case Rep J       Date:  2022-09-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.